COVID-19 vaccine-related interstitial lung disease: a case study

Affiliations

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea evan007@naver.com.
² Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea.
³ Department of Radiology, Hallym University College of Medicine, Anyang, South Korea.

Ji Young Park et al. Thorax. 2022 Jan.

. 2022 Jan;77(1):102-104.

doi: 10.1136/thoraxjnl-2021-217609. Epub 2021 Aug 6.

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea evan007@naver.com.
² Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea.
³ Department of Radiology, Hallym University College of Medicine, Anyang, South Korea.

No abstract available

Keywords: COVID-19; drug induced lung disease.

Conflict of interest statement

Competing interests: None declared.

Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination.
DeDent AM, Farrand E. DeDent AM, et al. Thorax. 2022 Jan;77(1):9-10. doi: 10.1136/thoraxjnl-2021-217985. Epub 2021 Sep 11. Thorax. 2022. PMID: 34510014 No abstract available.